who created tirzepatide FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes Mounjaro® (tirzepatide) injection and Zepbound®

More serious but less common side effects include pancreatitis, gallbladder disease, worsening of diabetic eye disease, and pulmonary aspiration under anesthesia or deep sedation

Topical protocol: Application: Thin layer to affected area Frequency: 1 to 2 times daily Duration: Until healing is complete or as directed Choosing the right administration route The optimal route depends on the therapeutic goal

Preservative systems The preservatives included in the formulation significantly impact shelf life

PATIENT SAFETY: ADRENAL DRAMA: HOW STRESS BECAME A MARKET Learning Objectives After completing this continuing education activity, pharmacists will be able to RECALL the physiology of cortisol, including its regulation and effects on the bodys major systems

Minimally Invasive Procedure FAMI is performed under local anesthesia, eliminating the risks associated with general anesthesia